PepGen (PEPG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.60, +2.77% vs the prior close of $2.53.
- Volume 1.20M shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PEPG rises 2.8% to $2.60. Closed at $2.60, +2.77% vs the prior close of $2.53. Day range $2.50–$2.69, opened at $2.56.
PEPG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PEPG rises 2.8% to $2.60
- Closed at $2.60, +2.77% vs the prior close of $2.53. Day range $2.50–$2.69, opened at $2.56.
- Volume was 1.20M shares, 1.3x its 50-day average of 923.71K.
- Price is -8.1% vs its 50-day average ($2.83) and -19.4% vs its 200-day average ($3.22).
- 52-week range $1.31–$7.80; today's close sits at 20% of that range, 66.7% below the 52-week high.
Oct 15, 2026 — PEPG jumps 9.1% to $2.53
- Closed at $2.53, +9.05% vs the prior close of $2.32. Day range $2.30–$2.60, opened at $2.30.
- Volume was 764.20K shares, 0.8x its 50-day average of 921.79K.
- Price is -10.4% vs its 50-day average ($2.83) and -22.0% vs its 200-day average ($3.24).
- 52-week range $1.31–$7.80; today's close sits at 19% of that range, 67.6% below the 52-week high.
Oct 14, 2026 — PEPG slides 7.2% to $2.32
- Closed at $2.32, -7.20% vs the prior close of $2.50. Day range $2.26–$2.49, opened at $2.44.
- Volume was 917.30K shares, 1.0x its 50-day average of 910.59K.
- Price is -17.6% vs its 50-day average ($2.81) and -28.9% vs its 200-day average ($3.26).
- 52-week range $1.31–$7.80; today's close sits at 16% of that range, 70.3% below the 52-week high.
Oct 13, 2026 — PEPG rises 0.4% to $2.50
- Closed at $2.50, +0.40% vs the prior close of $2.49. Day range $2.41–$2.60, opened at $2.48.
- Volume was 1.22M shares, 1.4x its 50-day average of 893.18K.
- Price is -10.9% vs its 50-day average ($2.81) and -23.8% vs its 200-day average ($3.28).
- 52-week range $1.31–$7.80; today's close sits at 18% of that range, 67.9% below the 52-week high.
Oct 12, 2026 — PEPG slides 5.0% to $2.49
- Closed at $2.49, -4.96% vs the prior close of $2.62. Day range $2.48–$2.61, opened at $2.61.
- Volume was 315.80K shares, 0.4x its 50-day average of 892.80K — lighter than usual.
- Price is -10.9% vs its 50-day average ($2.79) and -24.4% vs its 200-day average ($3.30).
- 52-week range $1.31–$7.80; today's close sits at 18% of that range, 68.1% below the 52-week high.
Oct 9, 2026 — PEPG jumps 10.1% to $2.62
- Closed at $2.62, +10.08% vs the prior close of $2.38. Day range $2.39–$2.65, opened at $2.39.
- Volume was 603.70K shares, 0.7x its 50-day average of 890.06K.
- Price is -5.7% vs its 50-day average ($2.78) and -20.8% vs its 200-day average ($3.31).
- 52-week range $1.31–$7.80; today's close sits at 20% of that range, 66.4% below the 52-week high.
Oct 8, 2026 — PEPG dips 0.8% to $2.38
- Closed at $2.38, -0.83% vs the prior close of $2.40. Day range $2.28–$2.45, opened at $2.38.
- Volume was 844.60K shares, 0.9x its 50-day average of 892.20K.
- Price is -13.8% vs its 50-day average ($2.76) and -28.4% vs its 200-day average ($3.32).
- 52-week range $1.31–$7.80; today's close sits at 16% of that range, 69.5% below the 52-week high.
Oct 7, 2026 — PEPG jumps 3.9% to $2.40
- Closed at $2.40, +3.90% vs the prior close of $2.31. Day range $2.28–$2.48, opened at $2.31.
- Volume was 642.80K shares, 0.7x its 50-day average of 891.80K.
- Price is -12.7% vs its 50-day average ($2.75) and -28.1% vs its 200-day average ($3.34).
- 52-week range $1.31–$7.80; today's close sits at 17% of that range, 69.2% below the 52-week high.
Oct 6, 2026 — PEPG dips 2.1% to $2.31
- Closed at $2.31, -2.12% vs the prior close of $2.36. Day range $2.26–$2.38, opened at $2.38.
- Volume was 590.20K shares, 0.7x its 50-day average of 890.56K.
- Price is -15.6% vs its 50-day average ($2.74) and -31.1% vs its 200-day average ($3.35).
- 52-week range $1.31–$7.80; today's close sits at 15% of that range, 70.4% below the 52-week high.
Oct 5, 2026 — PEPG jumps 3.5% to $2.36
- Closed at $2.36, +3.51% vs the prior close of $2.28. Day range $2.26–$2.39, opened at $2.30.
- Volume was 606.40K shares, 0.7x its 50-day average of 893.13K.
- Price is -13.5% vs its 50-day average ($2.73) and -29.9% vs its 200-day average ($3.37).
- 52-week range $1.31–$7.80; today's close sits at 16% of that range, 69.7% below the 52-week high.
Oct 2, 2026 — PEPG jumps 3.2% to $2.28
- Closed at $2.28, +3.17% vs the prior close of $2.21. Day range $2.22–$2.31, opened at $2.24.
- Volume was 744.40K shares, 0.8x its 50-day average of 894.81K.
- Price is -16.2% vs its 50-day average ($2.72) and -32.6% vs its 200-day average ($3.38).
- 52-week range $1.31–$7.80; today's close sits at 15% of that range, 70.8% below the 52-week high.
PEPG latest news & SEC filings
Every SEC filing by or about PEPG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$17.81M (prior year -$23.09M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.26 (prior year -$0.70) (loss narrowed vs Jun 30, 2025)
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade PEPG
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 4, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.43% (largest 10.1%). That is a volatile stock.
- Liquidity: about 876.54K shares (≈$2.28M) trade per day on average.
- 52-week position: $2.60 vs a range of $1.31–$7.80 (20% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Kasra Kasraian sold 1,233 shares on May 21, 2026.
- Latest filings: 8-K Aug 6, 2026; 10-Q Aug 6, 2026; 8-K Jun 22, 2026.
- Share count: 69.26M shares outstanding (Aug 2, 2026), +111.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PEPG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.56 | 2.69 | 2.50 | 2.60 | 1.20M |
| Oct 15, 2026 | 2.30 | 2.60 | 2.30 | 2.53 | 764.20K |
| Oct 14, 2026 | 2.44 | 2.49 | 2.26 | 2.32 | 917.30K |
| Oct 13, 2026 | 2.48 | 2.60 | 2.41 | 2.50 | 1.22M |
| Oct 12, 2026 | 2.61 | 2.61 | 2.48 | 2.49 | 315.80K |
| Oct 9, 2026 | 2.39 | 2.65 | 2.39 | 2.62 | 603.70K |
| Oct 8, 2026 | 2.38 | 2.45 | 2.28 | 2.38 | 844.60K |
| Oct 7, 2026 | 2.31 | 2.48 | 2.28 | 2.40 | 642.80K |
| Oct 6, 2026 | 2.38 | 2.38 | 2.26 | 2.31 | 590.20K |
| Oct 5, 2026 | 2.30 | 2.39 | 2.26 | 2.36 | 606.40K |
| Oct 2, 2026 | 2.24 | 2.31 | 2.22 | 2.28 | 744.40K |
| Oct 1, 2026 | 2.38 | 2.42 | 2.21 | 2.21 | 782.90K |
| Sep 30, 2026 | 2.34 | 2.53 | 2.34 | 2.42 | 2.15M |
| Sep 29, 2026 | 2.61 | 2.65 | 2.32 | 2.34 | 2.35M |
| Sep 28, 2026 | 2.55 | 2.64 | 2.46 | 2.59 | 740.00K |
| Sep 25, 2026 | 2.68 | 2.72 | 2.59 | 2.59 | 513.20K |
| Sep 24, 2026 | 2.71 | 2.71 | 2.63 | 2.68 | 657.40K |
| Sep 23, 2026 | 2.95 | 2.96 | 2.69 | 2.72 | 715.40K |
| Sep 22, 2026 | 2.84 | 3.03 | 2.82 | 2.98 | 523.50K |
| Sep 21, 2026 | 2.88 | 2.91 | 2.80 | 2.84 | 652.40K |
About PepGen
PepGen (PEPG) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOSTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1835597.
PEPG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Habib J Dable | Director | Jun 22, 2026 |
| Mitchell H. Finer | Director | Jun 22, 2026 |
| Heidi Henson | Director | Jun 22, 2026 |
| Laurie Keating | Director | Jun 22, 2026 |
| Peter Kolchinsky | Director | Jun 22, 2026 |
| Howard Mayer | Director | Jun 22, 2026 |
| James G Mcarthur | President and CEO | Mar 6, 2026 |
| Capital Management, L.P. Ra | Director | Jun 22, 2026 |
| Capital Healthcare Fund Lp Ra | Director | Jun 22, 2026 |
| Capital Nexus Fund Ii, L.P. Ra | Director | Jun 22, 2026 |
| Joshua Resnick | Director | Jun 22, 2026 |
| Rajeev M. Shah | Director | Jun 22, 2026 |
| Lisa Wyman | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Noel Donnelly | Chief Financial Officer | Mar 6, 2026 |
| Kasra Kasraian | Chief Technical Officer | May 26, 2026 |
| James G Mcarthur | President and CEO | Mar 6, 2026 |
| Paul Streck | EVP, Head of R&D | Mar 6, 2026 |
| Joseph Vittiglio | Chief Business & Legal Officer | Mar 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 21, 2026 | Kasra Kasraian | Sale | 1,233 | $1.41 |
| May 21, 2026 | Kasra Kasraian | Sale | 1,233 | $1.41 |
| May 21, 2026 | Kasra Kasraian | Sale | 1,233 | $1.41 |
| May 21, 2026 | Kasra Kasraian | Sale | 1,233 | $1.41 |
| Mar 4, 2026 | Paul Streck | Sale | 1,832 | $6.23 |
| Mar 4, 2026 | Paul Streck | Sale | 47 | $6.29 |
| Mar 4, 2026 | Paul Streck | Sale | 1,832 | $6.23 |
| Mar 4, 2026 | Paul Streck | Sale | 47 | $6.29 |
| Mar 4, 2026 | Paul Streck | Sale | 1,832 | $6.23 |
| Mar 4, 2026 | Paul Streck | Sale | 47 | $6.29 |
| Mar 4, 2026 | Paul Streck | Sale | 1,832 | $6.23 |
| Mar 4, 2026 | Paul Streck | Sale | 47 | $6.29 |
| Mar 4, 2026 | James G Mcarthur | Sale | 131 | $6.33 |
| Mar 4, 2026 | James G Mcarthur | Sale | 5,144 | $6.23 |
| Mar 4, 2026 | James G Mcarthur | Sale | 131 | $6.33 |
PEPG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-89.66M | -2.12 | $-81.64M |
| Dec 31, 2024 | — | $-89.98M | -2.85 | $-82.37M |
| Dec 31, 2023 | — | $-78.63M | -3.30 | $-69.00M |
| Dec 31, 2022 | — | $-69.10M | -4.42 | $-59.27M |
| Dec 31, 2021 | — | $-27.28M | -30.27 | $-22.60M |
Latest balance sheet: total assets $141.40M, total liabilities $21.86M, cash $22.76M (as of Jun 30, 2026).
PEPG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $2.41 |
| May 12, 2026 | 8-K Item 2.02 (results) | $1.68 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $6.76 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $5.13 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.19 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.54 |
| Feb 24, 2025 | 8-K Item 2.02 (results) | $2.29 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $5.63 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 6, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PEPG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.